9666 Olive Blvd., Suite 310
St. Louis 63132
United States of America, Missouri
Stock symbol: GMED
GenoMed, Inc. is a Next Generation Disease Management(tm)company which uses medical genomics to improve patient outcomes. Diseases due to genes with already existing drugs (such as the ACE gene) are just as interesting to us as genes which will require new drug development. We believe we can already deliver better health care for half the price.